Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

32 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Economic evaluation of antibiotic prophylaxis in small-cell lung cancer patients receiving chemotherapy: an EORTC double-blind placebo-controlled phase III study (08923).
Tjan-Heijnen VC, Caleo S, Postmus PE, Ardizzoni A, Burghouts JT, Buccholz E, Biesma B, Gorlia T, Crott R, Giaccone G, Debruyne C, Manegold C; European Organisation for Research Treatment of Cancer-Lung Cancer Group and Health Economics Unit. Tjan-Heijnen VC, et al. Among authors: burghouts jt. Ann Oncol. 2003 Feb;14(2):248-57. doi: 10.1093/annonc/mdg073. Ann Oncol. 2003. PMID: 12562652 Free article. Clinical Trial.
Value of estrogenic recruitment before chemotherapy: first randomized trial in primary breast cancer.
Bontenbal M, van Putten WL, Burghouts JT, Baggen MG, Ras GJ, Stiegelis WF, Beudeker M, Janssen JT, Braun JJ, van der Linden GH, van der Velden PC, van Geel AN, Helle P, Leisink M, Foekens JA, Klijn JG. Bontenbal M, et al. Among authors: burghouts jt. J Clin Oncol. 2000 Feb;18(4):734-42. doi: 10.1200/JCO.2000.18.4.734. J Clin Oncol. 2000. PMID: 10673514 Clinical Trial.
Role of recombinant interferon-gamma maintenance in responding patients with small cell lung cancer. A randomised phase III study of the EORTC Lung Cancer Cooperative Group.
van Zandwijk N, Groen HJ, Postmus PE, Burghouts JT, ten Velde GP, Ardizzoni A, Smith IE, Baas P, Sahmoud T, Kirkpatrick A, Dalesio O, Giaccone G. van Zandwijk N, et al. Among authors: burghouts jt. Eur J Cancer. 1997 Oct;33(11):1759-66. doi: 10.1016/s0959-8049(97)00174-3. Eur J Cancer. 1997. PMID: 9470829 Clinical Trial.
Feasibility, endocrine and anti-tumour effects of a triple endocrine therapy with tamoxifen, a somatostatin analogue and an antiprolactin in post-menopausal metastatic breast cancer: a randomized study with long-term follow-up.
Bontenbal M, Foekens JA, Lamberts SW, de Jong FH, van Putten WL, Braun HJ, Burghouts JT, van der Linden GH, Klijn JG. Bontenbal M, et al. Among authors: burghouts jt. Br J Cancer. 1998;77(1):115-22. doi: 10.1038/bjc.1998.18. Br J Cancer. 1998. PMID: 9459155 Free PMC article. Clinical Trial.
Comparative study of dose escalation versus interval reduction to obtain dose-intensification of epirubicin and cyclophosphamide with granulocyte colony-stimulating factor in advanced breast cancer.
Lalisang RI, Wils JA, Nortier HW, Burghouts JT, Hupperets PS, Erdkamp FL, Schouten HC, Blijham GH. Lalisang RI, et al. Among authors: burghouts jt. J Clin Oncol. 1997 Apr;15(4):1367-76. doi: 10.1200/JCO.1997.15.4.1367. J Clin Oncol. 1997. PMID: 9193328 Clinical Trial.
Continuous infusion of high-dose 5-fluorouracil in combination with leucovorin and recombinant interferon-alpha-2b in patients with advanced colorectal cancer. A Multicenter Phase II study.
Punt CJ, Burghouts JT, Croles JJ, van Liessum PA, de Mulder PH, Kamm Y. Punt CJ, et al. Among authors: burghouts jt. Cancer. 1993 Oct 1;72(7):2107-11. doi: 10.1002/1097-0142(19931001)72:7<2107::aid-cncr2820720708>3.0.co;2-m. Cancer. 1993. PMID: 8374869 Clinical Trial.
32 results